Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
With over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications.
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
With deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
Get a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Recombinant monoclonal antibody Fragment Fab to NCA-90. Technetium (99mTc) sulesomab (trade name LeukoScan) is a mouse monoclonal antibody labelled with technetium-99m, a radionuclide. It is approved for the imaging of infections and inflammations in patients with suspected osteomyelitis, and is being investigated for other purposes like the detection of soft tissue infections.
Target
NCA-90
Type
Fab' - G1
Immunogen
Partially purified carcinoembryonic antigen (CEA) derived from GW-39 human colon adenocarcinoma xenografts.
Species Reactivity
Human
Expression Host
E. coli
Applications
Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, IHC and most other immunological methods.
CAS
167747-19-5
Trade name
leukoscan
Specific Activity
Tested positive against native human antigen.
Protein Construction
Immunoglobulin G1,anti-(human NCA-90 granulocyte cell antigen) Fab" fragment (mouse monoclonalIMMU-MN3 g1-chain), disulfide with mousemonoclonal IMMU-MN3 light chain
Predicted N terminal
H chain: QVQLQES; L chain: SIVMTQT
Purity
>95.0% as determined by analysis by RP-HPLC.
Size
1mg
Storage
At -20°C for one year.
BACKGROUND
Antigen Description
One of the nonspecific cross-reacting antigens found to be expressed on a variety of cell types. In the nomenclature of CD antigens this protein has been given the designation CD66a. NCA-90 and NCA-50 have the same sequence and the same placement of glycosylation sites despite their differences in molecular masses.